Risk Factors for Human T Cell Lymphotropic Virus Type I among Injecting Drug Users in Northeast Brazil: Possibly Greater Efficiency of Male to Female Transmission

Memorias do Instituto Oswaldo Cruz

Volumn 94, Issue 1, 1999, Pages 13-18

  Dourado, Inês ^a   Andrade, Tarcísio ^a   Carpenter, Catherine L ^b   Galvão Castro, Bernardo ^c  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Bahia; Brazil; Human immunodeficiency virus type I (HIV 1); Human T cell lymphotropic virus type I II (HTLV I II); Injecting drug use; Snowball sampling

Indexed keywords

HTLV; HTLV I; HTLV II; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LYMPHOTROPIC VIRUS TYPE I; HUMAN T-LYMPHOTROPIC VIRUS 1;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BRAZIL; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MALE; PREVALENCE; RISK FACTOR; SEXUAL BEHAVIOR; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HTLV-I INFECTIONS; HUMANS; MALE; PREVALENCE; RISK FACTORS; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0032612205     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761999000100006     Document Type: Article

References (35)

1. Andrade TM, Dourado I, Galvão-Castro B 1998. Associations among HTLV-I, HTLV-II and HIV in injecting drug users in Salvador, Brazil. J Acquir Immune Defic Syndr Hum Retrov 18: 186-187.
2. Araujo CA, Casseb JSR, Neitzert E, Souza MLX, Mammano F, Del Mistro A, Chieco-Bianchi L 1994. HTLV-I and HTLV-II infections among HIV-1 seropositive patients in São Paulo, Brazil. Eur J Epidemiol 10: 165-171.
3. Bellei NCJ, Granato CFH, Tomyana H, Castelo A, Ferreira O 1996. HTLV infection in a group of prostitutes and their male sexual clients in Brazil: seroprevalence and risk factors. Trans R Soc Trop Med Hyg 90: 122-125.
4. Biernack P, Walford D 1981. Snowball sampling: Problems and techniques of chain referral sampling. Sociol Methods Research 2: 141-63.
5. Briggs NC, Battjes RJ, Cantor KP, Blattner WA, Yellin FM, Wilson S, Ritz LA, Weiss SH, Goedert JJ 1995. Seroprevalence of Human T cell lymphotropic virus types II infection, with and without human immunodeficiency virus type I coinfection, among US intravenous drug users. J Infect Dis 172: 51-58.
6. CDC 1990. Human T-Lymphotropic virus type-I screening in volunteer blood donors - US, 1989. Morb Mortal Wkly Rep 39: 915-921.
7. de Carvalho HB, Mesquita F, Massad E, Bueno RC, Lopes GT, Ruiz MA, Burattini MN 1996. HIV and infections of similar transmission patterns in drug injectors community of Santos, Brazil. J Acquir Immune Defic Syndr Hum Retrov 12: 84-92.
8. Des Jarlais DC, Friedman P, Hagan H, Friedman SR 1996. The protective efffect of AIDS-related behavioral change among injection drug users: a cross-national study. Am J Public Health 86: 1780-1785.
9. Dourado I, Andrade T, Galvão-Castro B 1998. Human T cell Lymphotropic Virus Type 1 (HTLV- I) in Northeast Brazil: Differences for male and female injecting drug users. J Acquir Immune Defic Syndr Hum Retrov (in press).
10. Feigal E 1991. Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity. J Infect Dis 164: 36-42.
11. Ferreira Jr OC, Vaz RC, Carvalho MB, Guerra C, Fabron AL, Rosemblit J, Hamerschlak N 1994. Human T-lymphotropic virus type I and type II infections and correlation with risk factors in blood donors from São Paulo, Brazil. Transfusion 35: 1-6.
12. Fleiss JL 1981. Statistical Methods for Rates and Proportions, John Wiley and Sons, New York, 321 pp.
13. Gabbai AA, Bordin JO, Vieira-Filho JBP, Kuroda A, Oliveira ASB, Cruz MV, Ribeiro AAF, Delaney SR, Henrad DR, Rosario J, Roman GC 1993. Selectivity of human T-lymphotropic virus type- I (HTLV-I) and HTLV-II infection among different populations in Brazil. Am J Trop Med Hyg 49: 664-671.
14. Galvão-Castro B, Loures L, Rodrigues L, Sereno A, Ferreira Jr OC, Franco LGP, Muller M, Sampaio DA, Santana A, Passos LM, Proietti F 1997. Distribution of Human T-cell Lymphotropic Virus type I among blood donors: a nationwide Brazilian study. Transfusion 37: 42.
15. Hesran JY Le, Delaporte E, Gaudebout C, Trebuck A, Schrijvers D, Josse R, Peeters M, Cheringou H, Dupont A, Larouze B 1994. Demographic factors associated with HTLV-1 infection in a Gabonese community. Int J Epidemiol 23: 812-817.
16. HTLV European Research Network 1996. The sero-epidemiology of human T-cell leukaemia/lymphoma viruses in Europe. J Acquir Immune Defic Syndr Hum Retrov 12: 1-10.
17. Ishak R, Harrington Jr WJ, Azevedo VN, Eiraku N, Ishak MOG, Guerreiro JF, Santos SB, Kubo T, Monken C, Alexander S, Hall WW 1995. Identification of human T cell lymphotropic virus type IIa infection in the Kayapo, an indigenous population of Brazil. AIDS Res Hum Retrov 11: 813821.
18. Kajiyama W, Kashiwagi S, Ikematsu H, Hayashi J Nomura H, Okochi K 1986. Intra-familial transmission of adult T-cell leukemia virus. J Infect Dis 154: 851-857.
19. Khabbaz RF, Onorato IM, Cannon RO, Hartley TM, Roberts B, Hosein B, Kaplan JE 1990. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 326: 375-80.
20. Lee HH, Weiss SH, Brown LS, Mildvan D, Shorty V, Saravolatz L, Chu A, Ginzburg HM, Markowitz N, Des Jarlais DC, Blattner WA, Allain JP 1990. Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the Middle Atlantic and Central Regions of the USA. J Infect Dis 162: 347-352.
21. Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen IS 1989. High rate of HTLV-II infection in seropositive intravenous drug users in New Orleans. Science 244: 471-475.
22. Lopes CS, Rodrigues LC, Sichieri R 1996. The lack of selection bias in a snowball sampled case-control study on drug abuse. Int J Epidemiol 25: 1267-1270.
23. Merino F, Robert Guroff M, Clark J, Bundo- Bracho M, Blattner WA, Gallo RC 1984. Natural antibodies to human T-cell leukemia/lymphoma virus in health Venezuelan population. Int J Cancer 34: 501-506.
24. Moreira ED, Ribeiro, TT, Swanson P, Filho CS, Melo A, Brites C, Badaró R, Toedter G, Lee H, Harrington Jr W 1993. Seroepidemiology of HTLV type I/II in Northeastern Brazil. J Acquir Immune Defic Syndr 6: 959-963.
25. Moreno-Carvalho OA, Santos JI, Di Gredico G, Galvão-Castro B 1992. Evidence of preferential female prevalence of HTLV-I associated tropical spastic paraparesis in Bahia-Brazil. Arq Neuro-Psiquiatria 50: 183-188.
26. Nicolosi A, Leite MLC, Musicco M, Molinari S, Lazarrin A 1992. Parental and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. Am J Epidemiol 135: 225-233.
27. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC 1980. Detection and isolation of type-C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneos T-cell lymphoma. Proc Nat Acad Sci 77: 7415-7419.
28. Poiesz BJ, Ruscetti FW, Reitz MS, Kalyanaraman VS, Gallo RC 1981. Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukemia. Nature 294: 268-271.
29. Pombo de Oliveira MS, Matutes E, Famadas LC, Schulz TF, Calabro ML, Nucci M, Andrada-Serpa MJ, Tedder RS, Weiss RA, Catovsky D 1990. Adult T-cell leukemia/lymphoma in Brazil and its relation to HTLV-I. Lancet 1: 45-48.
30. SAS Institute Inc 1995. SAS Proprietary Software Release 6.11. Licensed to the University of North Carolina at Chapel Hill. Cary, NC.
31. Stimson GV 1995. The health and social cost of drug injecting: the challenge to developing countries. Presented at the sixty international conference on the reduction of drug-related harm, Florence.
32. Taylor GP 1996. The epidemiology of HTLV-I in Europe. J Acquir Immune Defic Syndr Hum Retrov 13: S8-S14.
33. Tedder RS, Shanson DC, Jeffries DJ, Cheingsong-Popov R, Clapham P, Dalgleish A, Nagy K, Weiss RA 1984. Low prevalence in the UK of HTLV-I and HTLV-II in subjects with AIDS, with extended lymphoadenopathy, and at risk of AIDS. Lancet 2: 125-128.
34. Vasquez P, Sanchez G, Volante C, Vera L, Ramirez E, Soto G, Lee H 1991. Human T-lymphotropic virus I: new risk for Chilean population. Blood 78: 850.
35. WHO-World Health Organization 1993. WHO collaborative study group on drug abuse: an international comparative study of HIV prevalence and risk behavior among drug injectors in 13 cities. Bull Narc 45: 19-46.